PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
205.24 - 207.41
139.95 - 221.69
4.54M / 6.59M (Avg.)
37.59 | 5.48
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
2.86%
Some net income increase while AVGO is negative at -43.15%. John Neff would see a short-term edge over the struggling competitor.
1.75%
Some D&A expansion while AVGO is negative at -18.58%. John Neff would see competitor’s short-term profit advantage unless expansions here deliver big returns.
103.23%
Well above AVGO's 53.67% if it’s a large positive yoy. Michael Burry would see a bigger future tax burden vs. competitor’s approach.
5.71%
SBC growth while AVGO is negative at -1.00%. John Neff would see competitor possibly controlling share issuance more tightly.
132.91%
Well above AVGO's 99.28% if positive yoy. Michael Burry would see a risk of bigger working capital demands vs. competitor, harming free cash flow.
44.89%
AR growth while AVGO is negative at -239.20%. John Neff would note competitor possibly improving working capital while we allow AR to rise.
40.21%
Some inventory rise while AVGO is negative at -77.60%. John Neff would see competitor possibly benefiting from leaner stock if demand remains.
111.76%
AP growth well above AVGO's 122.58%. Michael Burry would be concerned about potential late payments or short-term liquidity strain relative to competitor.
306.80%
Growth well above AVGO's 127.43%. Michael Burry would see a potential hidden liquidity or overhead issue overshadowing competitor's approach.
17.65%
Lower 'other non-cash' growth vs. AVGO's 121.74%, indicating steadier reported figures. David Dodd would confirm no missed necessary write-downs or gains.
64.21%
Operating cash flow growth above 1.5x AVGO's 37.27%. David Dodd would confirm superior cost control or stronger revenue-to-cash conversion.
-31.75%
Negative yoy CapEx while AVGO is 14.09%. Joel Greenblatt would see a near-term FCF boost unless competitor invests for long-term advantage.
No Data
No Data available this quarter, please select a different quarter.
-21.79%
Negative yoy purchasing while AVGO stands at 97.95%. Joel Greenblatt sees a near-term liquidity advantage unless competitor’s new investments produce outsized returns.
-5.50%
Both yoy lines are negative, with AVGO at -77.22%. Martin Whitman suspects an environment prompting fewer sales or fewer maturities within the niche.
-5975.00%
We reduce yoy other investing while AVGO is 119175.00%. Joel Greenblatt sees a near-term cash advantage unless competitor’s intangible or side bets produce strong returns.
-130.45%
We reduce yoy invests while AVGO stands at 96.33%. Joel Greenblatt sees near-term liquidity advantage unless competitor’s expansions yield high returns.
No Data
No Data available this quarter, please select a different quarter.
-42.70%
Negative yoy issuance while AVGO is 129.41%. Joel Greenblatt sees a near-term advantage in avoiding dilution unless competitor invests more effectively with the new shares.
-16.61%
We cut yoy buybacks while AVGO is 0.00%. Joel Greenblatt would question if competitor is gaining a per-share edge unless expansions justify holding cash here.